DexCom (NASDAQ:DXCM – Get Free Report) had its price target increased by equities researchers at Citigroup from $101.00 to ...

allowing real-time access and analysis of blood glucose values from the Dexcom G6 and G7 Continuous Glucose Monitors. Achieving these goals will result in a fully functional mobile app capable of ...